Single Oral Challenge by Advanced Glycation End Products Acutely Impairs Endothelial Function in Diabetic and Nondiabetic Subjects

  1. Jaime Uribarri, MD1,
  2. Alin Stirban, MD2,
  3. Denise Sander, MS3,
  4. Weijing Cai, MD4,
  5. Monica Negrean, MS2,
  6. Cristina E. Buenting, MS3,
  7. Theodore Koschinsky, MD3 and
  8. Helen Vlassara, MD4
  1. 1Division of Nephrology, Department of Medicine, Mount Sinai School of Medicine, New York, New York
  2. 2Heart and Diabetes Center NRW, Ruhr-University of Bochum, Bad Oeynhausen, Germany
  3. 3German Diabetes Center, Heinrich-Heine-University, Duesseldorf, Germany
  4. 4Division of Diabetes and Aging Research, The Brookdale Department of Geriatrics, Mount Sinai School of Medicine, New York, New York
  1. Address correspondence and reprint requests to Jaime Uribarri, MD, Mount Sinai School of Medicine, One Gustave Levy Pl., New York, NY 10029. E-mail: jaime.uribarri{at}mssm.edu

Abstract

OBJECTIVE—The current study was designed to test the acute effects of dietary advanced glycation end products (AGEs) on endothelial function of diabetic and nondiabetic subjects.

RESEARCH DESIGN AND METHODS—Flow-mediated dilation (FMD) of the brachial artery and serum levels of AGEs, plasminogen activator inhibitor 1 (PAI-1), vascular cell adhesion molecule 1 (VCAM-1), and glucose were assessed before and after a single oral AGE challenge (∼1.8 × 106 AGE units) in 44 diabetic and 10 nondiabetic subjects.

RESULTS—The diabetic patients had higher baseline levels of serum AGEs (P = 0.020), PAI-1 (NS), and VCAM-1 (P = 0.033) and lower baseline values of FMD compared with nondiabetic subjects (P = 0.032). Ninety minutes after a single oral AGE challenge, serum AGEs and PAI-1 levels increased and FMD decreased significantly in both healthy subjects (AGEs: 7.2 ± 0.5 to 9.3 ± 1 units/ml, P = 0.014; PAI-1: 5.4 ± 0.4 to 6.8 ± 0.4 ng/ml, P = 0.007; and FMD: 9.9 ± 0.7 to 7.4 ± 0.9%, P = 0.019) and diabetic subjects (AGEs: 10.5 ± 0.7 to 14.2 ± 1 units/ml, P = 0.020; PAI-1: 6.5 ± 1 to 10 ± 2 ng/ml, P = 0.030; and FMD: 5.4 ± 0.4 to 4.0 ± 0.3%, P = 0.032). Serum glucose and VCAM-1 levels remained unchanged.

CONCLUSIONS—Significant increases in serum AGEs can occur together with altered clinical measures of endothelial function in diabetic and nondiabetic subjects after a single modest AGE-rich beverage. Thus, repeated or chronic exposure to high AGE diets could over time lead to and/or accelerate vascular disease.

Footnotes

  • Published ahead of print at http://care.diabetesjournals.org on 11 May 2007. DOI: 10.2337/dc07-0320.

    A table elsewhere in this issue shows conventional and Système International (SI) units and conversion factors for many substances.

    The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked “advertisement” in accordance with 18 U.S.C Section 1734 solely to indicate this fact.

    • Accepted April 29, 2007.
    • Received February 15, 2007.
« Previous | Next Article »Table of Contents

This Article

  1. Published online before print May 11, 2007, doi: 10.2337/dc07-0320 Diabetes Care October 2007 vol. 30 no. 10 2579-2582
  1. » Abstract
  2. Full Text
  3. Full Text (PDF)
  4. All Versions of this Article:
    1. dc07-0320v1
    2. 30/10/2579 most recent

Current Issue

  1. November 2009, 32 (11)
  1. Current Issue
  1. Alert me to new issues of Diabetes Care